Key Market Indicators
Finnish antacid medicine sales are predicted to reach nearly $5 million by 2026. Last year, the market was worth $4.5 million, an increase of 1.3% from the previous year. Since 2003, Finnish market growth has been a steady 5.2% annually. In 2021, it placed 11th, overtaken by the Czech Republic, which reached $4.5 million in sales. Italy, Germany and Chile came in at second, third and fourth place respectively.
